(NasdaqGM:OCS),(Iceland:OCS),(Iceland:OCS.IC), Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. alone Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 eye drops in diabetic macular edema (DME) expected in Q2 2026 Riad Sherif, […]

STEVENAGE, United Kingdom, Jan. 08, 2026 (GLOBE NEWSWIRE) — NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify mitochondrial dysfunction in neurodegenerative diseases, is pleased to announce that the first participants have been dosed in its first-in-human Phase 1 clinical trial of its lead candidate NRG5051 which is being

Wery AI Launches All-in-One Creative Suite to Simplify Professional Content Creation GlobeNewswire January 08, 2026 Singapore, Jan. 08, 2026 (GLOBE NEWSWIRE) — In a saturated landscape of fragmented AI tools, Wery AI (https://www.weryai.com/) is redefining the creative process with an all-in-one platform that puts powerful, professional-grade video and image generation at users' fingertips. By integrating

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference GlobeNewswire January 08, 2026 Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. alone Multiple milestones anticipated from late-stage portfolio including topline results

NRG Therapeutics Announces First Participants Dosed in its First-in-Human Phase 1 Clinical Trial of NRG5051 Which is Being Developed as a Disease-modifying Treatment for ALS/MND and Parkinson's GlobeNewswire January 08, 2026 STEVENAGE, United Kingdom, Jan. 08, 2026 (GLOBE NEWSWIRE) — NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company targeting a novel mechanism to rectify

Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors GlobeNewswire January 08, 2026 VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina”), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery and Variational AI, a leader in generative artificial intelligence for small-molecule

EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome GlobeNewswire January 08, 2026 Clinically meaningful improvements in global IBS symptom severity observed as early as Week 1 and sustained through Week 7, with EBX-102-02 outperforming placebo throughout the study (final assessment at Week

(NASDAQ:UTSI), HANGZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) — UTStarcom (“UTStarcom” or the “Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, today announced the launch of the SkyFlux SPN310, the newest addition to its cutting-edge SkyFlux Converged Packet Transport platform. The SkyFlux Converged Packet Transport Platform is a next-generation communications platform designed to transform network and

UTStarcom Launches SkyFlux SPN310 to Empower Enterprise and Metro Edge Networks GlobeNewswire January 08, 2026 HANGZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) — UTStarcom (“UTStarcom” or the “Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, today announced the launch of the SkyFlux SPN310, the newest addition to its cutting-edge SkyFlux Converged Packet Transport platform. The SkyFlux

Zenwork’s membership in NACTP will allowâ?¯Zenwork to deepen its involvement in national efforts to modernize electronic filing and data security standards, expanding access to secure, automated tax compliance solutions for tax professionals. FAYETTEVILLE, AR / ACCESS Newswire / January 8, 2026 / Zenwork, Inc., the leading provider of digital tax compliance and information-reporting solutions and